INTERNATIONAL PATENT: TESSERA THERAPEUTICS, INC. FILES APPLICATION FOR "MODIFIED ST1CAS9 GUIDE NUCLEIC ACIDS"

GENEVA, Sept. 22 -- TESSERA THERAPEUTICS, INC. (101 South StreetSuite 300Somerville, Massachusetts 02143) filed a patent application (PCT/US2025/020065) for "MODIFIED ST1CAS9 GUIDE NUCLEIC ACIDS" on Mar 14, 2025. With publication no. WO/2025/194124, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DONG, Xiaolong (c/o Tessera Therapeutics, Inc.101 South StreetSuite 300Somerville, Massachusetts 02143), BOTHMER, Anne Helen (c/o Tessera Therapeutics, Inc.101 South StreetSuite 300Somerville, Massachusetts 02143), MIR, Aamir (c/...